AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Instrument and reagent vendors at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
109 instrument and reagent vendors are at AMP 2026 — 69 presentations on the program and 102 with a booth in the exhibit hall. Most represented: Promega (3 on the program), Illumina (2 on the program), Bio-Rad Laboratories (2 on the program). 41 of them have their own page in this guide. As of Nov 12, 2026.
Program track
Top represented
Showing 1–10 of 109 organizations
| Organization | AMP 2026 Attendance |
|---|---|
Promega Madison, WI | |
Nucleic acid extraction, PCR reagents and custom or OEM manufacturing for clinical laboratories, with technical support. | Booth Exhibiting at Booth 610 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am From Hands-On to Hands-Off: Automating FFPE, Blood, and Bone Marrow Extraction on the Clear Dx System Automated nucleic acid extraction from FFPE, blood and bone marrow, with yield reproducibility, contamination checks and time saved. Workshop Wed, Nov 11 9:00am–9:50am OncoMate® MSI Dx as a Companion Diagnostic for Microsatellite Instability: Clinical Context, Validation, and Performance Microsatellite instability testing as a companion diagnostic for checkpoint inhibitor eligibility, with accuracy and concordance data. |
Illumina San Diego, CA | |
Sequencing instruments and reagents for clinical, research and applied markets, spanning oncology, reproductive health and genetic disease. | Booth Exhibiting at Booth 727, MR1, MR2 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Gold Partner Workshop Wed, Nov 11 11:00am–11:50am Expanding Precision Oncology: Practical Strategies for Integrating Tissue and Liquid Biopsy Comprehensive Genomic Profiling Tissue and liquid biopsy genomic profiling run side by side, covering test algorithms, lab operations and case examples. Workshop Wed, Nov 11 12:00pm–12:50pm Genome as a Platform: Advancing MRD Research with Illumina Whole Genome Sequencing Oncology Prep Whole-genome sequencing as a single platform for molecular residual disease research, with early analytical performance data. Workshop Wed, Nov 11 2:00pm–2:50pm Unlocking AML Biology with 5-Base Whole-Genome Sequencing: Integrated Genomic and Epigenomic Profiling for Biomarker Discovery Five-base whole-genome sequencing reads methylation and genomic variation from one AML sample to find research biomarkers. Workshop Fri, Nov 13 3:00pm–3:30pm Comprehensive Tumor Profiling Beyond Panels: Methylation-Aware WGS Enabled by Advanced Informatics Whole-genome sequencing with methylation and fragmentomic analysis moves tumor profiling beyond targeted panels, using DRAGEN informatics. |
Bio-Rad Laboratories Hercules, CA | |
Products for life science research and clinical diagnostics, including droplet digital PCR, real-time PCR and molecular quality controls and standards. | Booth Exhibiting at Booth 537, MR16 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am MRD Detection & Monitoring in Solid Tumors and Heme Malignancies Using Personalized Tumor Informed Droplet Digital PCR (ddPCR) Assays in Research Settings Tumour-informed droplet digital PCR assays for tracking residual disease in both blood cancers and solid tumours. Workshop Thu, Nov 12 6:15pm–6:45pm Unlocking More from Every Sample: New Multiplex Oncology Assays and Emerging MRD Applications with the QX700™ ddPCR™ System Multiplexed droplet digital PCR assays that pull more oncology biomarker data from limited samples, including residual disease monitoring. |
New England Biolabs Ipswich, MA | |
Molecular biology reagents and enzymes for PCR and qPCR, sequencing library preparation, genome editing, epigenetics, synthetic biology and RNA analysis. | Booth Exhibiting at Booth 922, MR15 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 10:00am–10:50am One Sample, Many Insights: Multiomic Profiling in cfDNA and cfRNA Samples Running cfDNA and cfRNA analysis from one liquid biopsy sample, with NEB extraction and NGS library preparation workflows. |
Cellecta Mountain View, CA | |
Genomic products and services for drug target and biomarker discovery: viral vector production, functional screening, cell engineering and multiplex qRT-PCR. | Booth Exhibiting at Booth 2205 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm From Repertoire to Response: A Workflow for Mapping Antigen-Specific T- and B-Cell Clonotypes for Receptor-Based Target Discovery Pairing immune receptor sequencing with antigen screening to rank tumour-specific T- and B-cell clonotypes, including from plasma. Workshop Sat, Nov 14 9:30am–10:00am Discovery and Validation of T- and B-Cell Clonotypes to Drive Next-Level Drug and Biomarker Discovery An end-to-end route from bulk and single-cell receptor sequencing to screening that surfaces drug and biomarker candidates. |
Countable Labs Palo Alto, CA | |
Countable PCR uses single-molecule isolation for fusion and rare variant detection, minimal residual disease monitoring and absolute ctDNA quantification. | Booth Exhibiting at Booth 943 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 12:00pm–12:50pm A New Detection Paradigm for Heme Oncology: High-Color Single-Molecule PCR for Reproducible MRD and Monitoring Single-molecule PCR across millions of partitions to count BCR::ABL1, KMT2A and other blood cancer variants reproducibly. |
Covaris Woburn, MA | |
Sample preparation for multiomics research and clinical labs, using focused-acoustics instruments, consumables, reagents and kits. A PerkinElmer company. | Booth Exhibiting at Booth 2409 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 3:00pm–3:50pm Optimizing FFPE tissue stewardship: Covaris truXTRAC® automated workflow delivers excellent performance for tumor-informed Haystack MRD® assay Getting more DNA and RNA from each FFPE slide so scarce tumour tissue stretches across several sequencing assays. Workshop Thu, Nov 12 3:45pm–4:15pm Optimized Automated Extraction for FFPE Tissue Cores Automated simultaneous DNA and RNA extraction from FFPE cores and sections, validated for sequencing-grade yield. |
PacBio Menlo Park, CA | |
Sequencing technologies combining long reads with high accuracy for genomes, transcriptomes and epigenomes. | Booth Exhibiting at Booth 1018 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 9:00am–9:50am Full Stack Somatic: Connecting Long-Read HiFi WGS to Clinical Genomic Reporting A containerized somatic long-read whole-genome pipeline running from raw data through variant interpretation to a clinical report. Workshop Fri, Nov 13 12:00pm–12:30pm Accelerating Clinical Genomics with HiFi Sequencing: Targeted and Rapid Whole-Genome Workflows Long-read workflows for repeat expansion disorders and other hard genomic regions, plus a faster whole-genome protocol. |
Vazyme Nanjing, China | |
Designs and manufactures bioactive proteins and recombinant enzymes plus high-performance materials for life science research and in vitro diagnostics. | Booth Exhibiting at Booth 1803 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 1:00pm–1:50pm Intelligent Labs Era: Full Premix Technology Paves the Way for High-Efficiency qPCR A single-tube premixed qPCR formulation aimed at fewer pipetting steps and steadier amplification results. |
Thermo Fisher Scientific Waltham, MA | |
Research and diagnostic solutions for molecular laboratories: next-generation sequencing, real-time PCR, Sanger sequencing and bioinformatics across oncology, pharmacogenomics and infectious disease. | Booth Exhibiting at Booth 709, MR10, MR4 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Silver Partner Workshop Wed, Nov 11 10:00am–10:50am Beyond Tissue: Implementing Alternative Analytes for Molecular Diagnostics in Clinical Practice Using cerebrospinal fluid and fine needle aspirate supernatant for sequencing when tumour tissue is scarce or unavailable. Workshop Wed, Nov 11 11:00am–11:50am Novel NGS Applications in Oncology Research: TCR Sequencing and Methylation-Based ctDNA Analysis T-cell receptor sequencing and methylation-based circulating tumor DNA analysis open new angles on immune response and tumor signals. Workshop Wed, Nov 11 12:00pm–12:50pm Workshop Wed, Nov 11 1:00pm–1:50pm Implementing Clinical Pharmacogenomics: Practical Lessons from Assay to Actionable Care Getting pharmacogenomic testing into routine care: test selection, lab workflow, reporting, reimbursement and health record integration. Workshop Wed, Nov 11 2:00pm–2:50pm Advancing Precision Oncology Research: Integrating Pharmacogenomics and Genomic Profiling Using a Single, Rapid NGS Workflow on the Genexus System Folding DPYD pharmacogenomic content into tumour sequencing so one run covers both drug-response and tumour profiling. Workshop Wed, Nov 11 3:00pm–3:50pm Bridging the Clinical Gap: Retrospective Microsatellite Instability Testing to Inform Complex Biospecimen Cohort Generation Microsatellite instability testing across hundreds of banked tumor specimens builds characterized cohorts for immunotherapy research. Workshop Wed, Nov 11 8:00am–8:50am The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions. Workshop Wed, Nov 11 9:00am–9:50am From Assay to Answer: Genomic Technologies and Multiplex Workflow Solutions for Infectious Disease Research Pathogen detection by qPCR and digital PCR, with assay design and multiplexing choices for adding targets within one reaction. Workshop Thu, Nov 12 4:25pm–4:55pm It's Hard to Treat What You Can't See: Leveraging Molecular Diagnostics to Improve Care of Patients with Pancreatic Lesions Pancreatic lesions are hard to call on imaging and cytology alone; molecular testing can sharpen diagnosis and risk stratification. Workshop Thu, Nov 12 6:15pm–6:45pm Unlocking New Possibilities in Myeloid Malignancies MRD Assessment with NGS An NGS assay for measurable residual disease in myeloid cancers, covering its gene content, workflow and reported performance. |
Find buyers from instrument and reagent vendors
Tell us what you sell and we’ll find the people at these instrument and reagent vendors most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse AMP 2026 by
Organization type
Program track
Exhibit hall
Everyone
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction